CDC- BRFSS – ACBS 2020 Adult Prevalence Table 6
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 315 | 32.1 | 4.3 | (23.7 – 40.5) |
| Connecticut | 298 | 28.7 | 4.4 | (20.1 – 37.3) |
| Florida | 284 | 29.0 | 4.4 | (19.0 – 39.0) |
| Georgia | 274 | 34.0 | 5.0 | (24.2 – 43.8) |
| Hawaii | 233 | 29.6 | 4.0 | (21.8 – 37.4) |
| Indiana | 291 | 32.5 | 3.9 | (24.9 – 40.1) |
| Iowa | 279 | 34.5 | 3.4 | (27.8 – 41.2) |
| Kansas | 226 | 36.2 | 4.6 | (27.2 – 45.2) |
| Maine | 396 | 31.2 | 4.4 | (22.6 – 39.8) |
| Maryland | 148 | 20.9 | 4.3 | (12.5 – 29.3) |
| Massachusetts | 238 | 32.9 | 4.3 | (24.5 – 41.3) |
| Michigan | 324 | 48.2 | 3.9 | (40.6 – 55.8) |
| Minnesota | 475 | 32.7 | 2.8 | (27.2 – 38.2) |
| Missouri | 253 | 38.7 | 4.6 | (29.7 – 47.7) |
| Montana | 238 | 26.3 | 4.2 | (18.1 – 34.5) |
| Nebraska | 421 | 40.0 | 3.7 | (32.7 – 47.3) |
| New Hampshire | 374 | 37.8 | 3.7 | (30.5 – 45.1) |
| New Jersey | 448 | 35.5 | 3.1 | (29.4 – 41.6) |
| New Mexico | 244 | 35.6 | 5.0 | (25.8 – 45.4) |
| New York | 178 | 36.1 | 4.9 | (26.5 – 45.7) |
| Ohio | 408 | 32.1 | 3.6 | (25.0 – 39.2) |
| Oregon | 232 | 27.1 | 3.3 | (20.6 – 33.6) |
| Pennsylvania | 177 | 42.2 | 5.6 | (31.2 – 53.2) |
| Rhode Island | 235 | 40.4 | 5.3 | (30.0 – 50.8) |
| Texas | 393 | 35.0 | 5.4 | (24.4 – 45.6) |
| Utah | 367 | 30.4 | 3.1 | (24.3 – 36.5) |
| Vermont | 377 | 29.7 | 3.3 | (23.2 – 36.2) |
| Wisconsin | 227 | 32.8 | 4.2 | (24.6 – 41.0) |
| Puerto Rico | 221 | 46.9 | 5.3 | (36.5 – 57.3) |
| 29 States / Area | 8,574 | 35.0 | 1.1 | (32.8 – 37.2) |
| Median | 32.9 | |||
| Range | 20.9-48.2 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf